| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002936 Methods and compositions useful for inhibition of angiogenesis |
| 01/06/2005 | US20050002931 GBS toxin receptor |
| 01/06/2005 | US20050002929 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/06/2005 | US20050002925 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them |
| 01/06/2005 | US20050002920 Collecting, activating, culturing and optionally expanding peripheral blood mononuclear cells then hypomethylating with 5-aza-cytidine or 5-aza-2'-deoxycytidine |
| 01/06/2005 | US20050002917 Regulation of Acheron expression |
| 01/06/2005 | US20050002914 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 01/06/2005 | US20050002902 Increasing active half life; reducing dosage and side effects |
| 01/06/2005 | US20050002898 N-TRADD active site and uses thereof |
| 01/06/2005 | US20050002875 Peptide which binds to integrin |
| 01/06/2005 | CA2839032A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/06/2005 | CA2538349A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| 01/06/2005 | CA2530386A1 Antibodies against interleukin-22 and uses therefor |
| 01/06/2005 | CA2530248A1 Modified vectors for organelle transfection |
| 01/06/2005 | CA2530111A1 Glycogen synthase kinase-3 inhibitors |
| 01/06/2005 | CA2530020A1 Novel .beta.-actin and rps21 promoters and uses thereof |
| 01/06/2005 | CA2529660A1 Vegf traps and therapeutic uses thereof |
| 01/06/2005 | CA2529145A1 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
| 01/06/2005 | CA2528591A1 Glp-1 analog fusion proteins |
| 01/06/2005 | CA2528544A1 Compositions and methods for regulating polysaccharides of a plant cell |
| 01/06/2005 | CA2528536A1 Transcription factors |
| 01/06/2005 | CA2528511A1 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | CA2528343A1 Modulating the interaction between hgf beta chain and c-met |
| 01/06/2005 | CA2528067A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | CA2527636A1 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | CA2526490A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/06/2005 | CA2526343A1 Ancestral viruses and vaccines |
| 01/06/2005 | CA2526284A1 Binding molecules for the treatment of myeloid cell malignancies |
| 01/06/2005 | CA2526023A1 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 01/06/2005 | CA2525333A1 Trichoderma genes |
| 01/06/2005 | CA2506821A1 Chemically-modified human growth hormone conjugates |
| 01/05/2005 | EP1494031A2 Novel human genes and gene expression products |
| 01/05/2005 | EP1493825A2 Method for producing nucleic acid ligands |
| 01/05/2005 | EP1493817A1 Resistance against plant pests |
| 01/05/2005 | EP1493815A1 Novel fusion protein recovery and purification methods |
| 01/05/2005 | EP1493813A1 Flagellar genetic sequences of Brucella being of therapeutic and diagnostic use |
| 01/05/2005 | EP1493812A2 A truncated keratinocyte growth factor (KGF) having increased biological activity |
| 01/05/2005 | EP1493811A1 Novel promoters |
| 01/05/2005 | EP1493750A2 HCV regulated proteins |
| 01/05/2005 | EP1493749A1 Novel HCV core + 1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents |
| 01/05/2005 | EP1493748A1 Peptide chemically modified with polyethylene glycol |
| 01/05/2005 | EP1493747A1 Process for producing modified peptide |
| 01/05/2005 | EP1493446A1 Modified truncated complement system regulators |
| 01/05/2005 | EP1493034A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1492884A2 Methods of diagnosing and treating colorectal cancer |
| 01/05/2005 | EP1492881A2 Use of biological photoreceptors as directly light-activated ion channels |
| 01/05/2005 | EP1492879A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
| 01/05/2005 | EP1492878A1 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 01/05/2005 | EP1492870A2 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 01/05/2005 | EP1492867A2 Identification of virulence associated regions rd1 and rd5 enabling the development of imrpoved vaccines of m. bovis bcg and m. microti |
| 01/05/2005 | EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 01/05/2005 | EP1492815A2 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 01/05/2005 | EP1492814A2 Novel peptides and the application thereof in therapy |
| 01/05/2005 | EP1492813A2 Ox40r binding agents |
| 01/05/2005 | EP1492812A2 Modulator of the notch signalling pathway and use thereof in medical treatment |
| 01/05/2005 | EP1492811A1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 01/05/2005 | EP1492810A2 Novel fluorescent proteins |
| 01/05/2005 | EP1492809A2 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity |
| 01/05/2005 | EP1492808A2 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 01/05/2005 | EP1492807A2 Novel proteins and nucleic acids encoding same |
| 01/05/2005 | EP1492806A2 Human smooth muscle myosin heavy chain |
| 01/05/2005 | EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/05/2005 | EP1492562A2 Virus-like particles of human papillomavirus |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492558A2 Novel secreted proteins and their uses |
| 01/05/2005 | EP1492557A2 Xcrf polynucleotides and polypeptides and uses thereof |
| 01/05/2005 | EP1492554A2 Spherical protein particles and methods of making and using them |
| 01/05/2005 | EP1492476A1 Device for mixing and/or injecting cements |
| 01/05/2005 | EP1492440A2 A new method for the diagnosis and prognosis of malignant diseases |
| 01/05/2005 | EP1456349A4 Expression system |
| 01/05/2005 | EP1448760A4 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 01/05/2005 | EP1402451A4 Solution structure of il-13 and uses thereof |
| 01/05/2005 | EP1397386A4 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 01/05/2005 | EP1390535A4 Combinatorial libraries of monomer domains |
| 01/05/2005 | EP1381268A4 Method for modifying plant biomass |
| 01/05/2005 | EP1301202A4 Genetically-engineered mhc molecules |
| 01/05/2005 | EP1211933A4 Pa28 modified transgenic mice |
| 01/05/2005 | EP1102841A4 Method for selective and optionally reversible degeneration of somatic plant tissue |
| 01/05/2005 | EP1015014A4 Methods and compositions for inhibiting angiogenesis |
| 01/05/2005 | EP0994956B1 Male tissue-preferred regulatory region and method of using same |
| 01/05/2005 | EP0719333B1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 01/05/2005 | EP0699078B1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | DE10325026A1 Bakterien mit erhöhter Proteinsekretion, Nukleotidsequenzen codierend für ein SecA Protein mit erhöhter Proteinsekretion sowie Verfahren zur Produktion von Proteinen Bacteria with increased protein secretion, nucleotide sequences coding for a protein with increased SecA protein secretion as well as methods for producing proteins |
| 01/05/2005 | CN1561395A Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 01/05/2005 | CN1561394A Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 01/05/2005 | CN1561389A Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 01/05/2005 | CN1561343A Soluble T cell receptor |
| 01/05/2005 | CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561225A Modulation of leukocyte-endothelial interactions following ischemia |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1561164A 抗微生物剂 Antimicrobial agent |
| 01/05/2005 | CN1560255A Coding sequence of Chinese yew tarad-ane C13-lateral chain-N-benzoyl transiting enzymic protein |
| 01/05/2005 | CN1560250A Coding sequence of Chinese yew agglutinant protein |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560243A Extracting process of actinidia proteinase |